Treatment with Tucatinib in Addition to Pertuzumab and Trastuzumab in Patients with HER2-positive Metastatic Breast Cancer (HER2+MBC) after Local Therapy of Isolated Brain Progression: InTTercePT, a UCBG/GINECO Study
CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要